Conceptual framework for the definition of disease modification in systemic sclerosis and potential implications for drug development and clinical study design

By afschroeder • September 15, 2026

Distler JHW, Assassi S, Gabrielli A, Allanore Y, Chung L, Cutolo M, Galdo FD, De Vries-Bouwstra JK, Domsic RT, Elhai M, Frech T, Hinchcliff M, Homey B, Khanna D, Krieg T, Kuwana M, Lescoat A, Low AHL, Matucci-Cerinic M, McMahan ZH, Molitor JA, Mouthon L, Nikpour M, Riemekasten G, Spierings J, Truchetet ME, Smith V, Varga J, Volkmann E, Vonk MC, Wang J, Xu D, Zhu H, Hoffmann-Vold AM, Denton CP, Distler O. Conceptual framework for the definition of disease modification in systemic sclerosis and potential implications for drug development and clinical study design. Ann Rheum Dis. 2026 Sep 14:S0003-4967(26)00491-7. doi: 10.1016/j.ard.2026.08.006. Epub ahead of print. PMID: 42736088.

Tags: Publications, Rheumatology

A trial emulation study indirectly comparing tafamidis and acoramidis in transthyretin amyloid cardiomyopathy: the ReplicATTR study

Debonnaire P, Zwetsloot PP, Pfister R, Llàcer P, Cipriani A, Milani P, Bonderman D, Ohlmeier C, Evers T, Wyss R, Patorno E, Doshi R, Beisel[...]

Examining the Interchangeability of Two Different Patient-Reported Global Assessment Measures in an Observational Axial Spondyloarthritis Cohort

Vershel C, Kim S, Gensler LS, Brown MA, Weisman MH, Ishimori ML, Ward M, Reveille JD, Hwang MC. Examining the Interchangeability of Two Different Patient-Reported[...]

An implantable wireless battery-free spatially selective vagus nerve stimulator

Rutkovskis E, Ravagli E, Lancashire HT, Shah Idil A, Thompson N, Perkins JD, Challita R, Hadaya J, Vivekananda U, Ajijola O, Shivkumar K, Miserocchi A,[...]